Diabetes and CVD risk during angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker treatment in hypertension: a study of 15 990 patients.

Published in:

Journal of Human Hypertension, 2014, v. 28, n. 11, p. 663, doi. 10.1038/jhh.2014.43

By:

• Hasvold, L P;
• Bodegård, J;
• Thuresson, M;
• Stålhammar, J;
• Hammar, N;
• Sundström, J;
• Russell, D;
• Kjeldsen, S E

Publication type:

Article